Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma
Blood Cancer J
.
2024 Sep 19;14(1):164.
doi: 10.1038/s41408-024-01136-1.
Authors
Malin Hultcrantz
1
,
Hani Hassoun
2
,
Neha Korde
2
,
Kylee MacLachlan
2
,
Sham Mailankody
2
,
Dhwani Patel
2
,
Urvi A Shah
2
,
Carlyn Rose Tan
2
,
David J Chung
3
,
Oscar B Lahoud
3
,
Heather J Landau
3
,
Michael Scordo
3
,
Gunjan L Shah
3
,
Sergio A Giralt
3
,
Matthew J Pianko
4
,
Miranda Burge
2
,
Kelly Barnett
2
,
Meghan Salcedo
2
,
Julia Caple
2
,
Linh Tran
2
,
Jenna Blaslov
2
,
Tala Shekarkhand
2
,
Selena Hamid
2
,
David Nemirovsky
5
,
Andriy Derkach
5
,
Oluwatobi Arisa
6
,
Cody J Peer
6
,
William D Figg
6
,
Saad Z Usmani
2
,
Ola Landgren
#
7
,
Alexander M Lesokhin
#
2
Affiliations
1
Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[email protected]
.
2
Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
3
Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
4
Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
5
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
6
Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
7
Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
#
Contributed equally.
PMID:
39300066
PMCID:
PMC11412964
DOI:
10.1038/s41408-024-01136-1
No abstract available
Publication types
Letter
MeSH terms
Aged
Diarrhea* / chemically induced
Female
Humans
Lenalidomide* / adverse effects
Lenalidomide* / therapeutic use
Male
Middle Aged
Multiple Myeloma* / complications
Multiple Myeloma* / drug therapy
Substances
Lenalidomide
Grants and funding
P30 CA008748/CA/NCI NIH HHS/United States